Market News
Arbutus Biopharma (ABUS): FY19 Earnings Snapshot
— Arbutus Biopharma Corporation (NASDAQ:ABUS) reported a net loss of $164.9 million or $2.89 per share for fiscal 2019, compared to a loss of $67.2…